nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—artery—metabolic syndrome X	0.0529	0.129	CbGeAlD
Amlexanox—FGF1—endothelium—metabolic syndrome X	0.0447	0.109	CbGeAlD
Amlexanox—FGF1—blood vessel—metabolic syndrome X	0.0412	0.1	CbGeAlD
Amlexanox—S100A13—cardiovascular system—metabolic syndrome X	0.0299	0.0726	CbGeAlD
Amlexanox—S100A12—cardiovascular system—metabolic syndrome X	0.0295	0.0716	CbGeAlD
Amlexanox—S100A13—adipose tissue—metabolic syndrome X	0.0263	0.064	CbGeAlD
Amlexanox—S100A12—adipose tissue—metabolic syndrome X	0.026	0.0631	CbGeAlD
Amlexanox—S100A13—liver—metabolic syndrome X	0.0185	0.0449	CbGeAlD
Amlexanox—FGF1—cardiovascular system—metabolic syndrome X	0.0184	0.0447	CbGeAlD
Amlexanox—S100A12—liver—metabolic syndrome X	0.0182	0.0443	CbGeAlD
Amlexanox—FGF1—kidney—metabolic syndrome X	0.018	0.0437	CbGeAlD
Amlexanox—PDE4D—adipose tissue—metabolic syndrome X	0.0173	0.0421	CbGeAlD
Amlexanox—FGF1—adipose tissue—metabolic syndrome X	0.0162	0.0394	CbGeAlD
Amlexanox—PDE4A—adipose tissue—metabolic syndrome X	0.0153	0.0373	CbGeAlD
Amlexanox—PDE4D—liver—metabolic syndrome X	0.0122	0.0295	CbGeAlD
Amlexanox—FGF1—liver—metabolic syndrome X	0.0114	0.0276	CbGeAlD
Amlexanox—PDE4B—adipose tissue—metabolic syndrome X	0.00915	0.0222	CbGeAlD
Amlexanox—PDE4B—liver—metabolic syndrome X	0.00641	0.0156	CbGeAlD
Amlexanox—S100A12—Immune System—CRP—metabolic syndrome X	0.000509	0.000865	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—IL6—metabolic syndrome X	0.000507	0.000861	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000505	0.000858	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—IL6—metabolic syndrome X	0.000504	0.000857	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOB—metabolic syndrome X	0.000502	0.000854	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—IL6—metabolic syndrome X	0.000502	0.000853	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOC3—metabolic syndrome X	0.0005	0.00085	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CRP—metabolic syndrome X	0.0005	0.000849	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—IL6—metabolic syndrome X	0.000499	0.000849	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—AKT1—metabolic syndrome X	0.000497	0.000845	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HDAC3—metabolic syndrome X	0.000497	0.000845	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TRIB3—metabolic syndrome X	0.000492	0.000836	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RBP4—metabolic syndrome X	0.000492	0.000836	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL5—metabolic syndrome X	0.00049	0.000833	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AGT—metabolic syndrome X	0.00049	0.000833	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—AKT1—metabolic syndrome X	0.00049	0.000832	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000489	0.00083	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000485	0.000825	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CYBA—metabolic syndrome X	0.000484	0.000822	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00048	0.000816	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—LPL—metabolic syndrome X	0.00048	0.000815	CbGpPWpGaD
Amlexanox—FGF1—Disease—HMGA1—metabolic syndrome X	0.00047	0.000799	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—IL6—metabolic syndrome X	0.00047	0.000798	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—IL6—metabolic syndrome X	0.00047	0.000798	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—IL6—metabolic syndrome X	0.00047	0.000798	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RBP4—metabolic syndrome X	0.000468	0.000795	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000468	0.000795	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—AKT1—metabolic syndrome X	0.000468	0.000794	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—IL6—metabolic syndrome X	0.000466	0.000791	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—AKT1—metabolic syndrome X	0.000465	0.000791	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000464	0.000788	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL5—metabolic syndrome X	0.000463	0.000787	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—AKT1—metabolic syndrome X	0.000463	0.000787	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—IL6—metabolic syndrome X	0.000461	0.000784	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000461	0.000784	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—AKT1—metabolic syndrome X	0.000461	0.000783	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—IL6—metabolic syndrome X	0.000459	0.000781	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—metabolic syndrome X	0.000454	0.000772	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HTR2C—metabolic syndrome X	0.000452	0.000767	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000449	0.000763	CbGpPWpGaD
Amlexanox—FGF1—Disease—GOT2—metabolic syndrome X	0.000449	0.000762	CbGpPWpGaD
Amlexanox—FGF1—Disease—CYBA—metabolic syndrome X	0.000447	0.000759	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AGT—metabolic syndrome X	0.000445	0.000756	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IRS1—metabolic syndrome X	0.000445	0.000755	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000444	0.000755	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000441	0.000749	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000439	0.000746	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CYBA—metabolic syndrome X	0.000437	0.000743	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IRS1—metabolic syndrome X	0.000436	0.000741	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOC3—metabolic syndrome X	0.000436	0.00074	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—metabolic syndrome X	0.000433	0.000736	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—AKT1—metabolic syndrome X	0.000433	0.000736	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—AKT1—metabolic syndrome X	0.000433	0.000736	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TRIB3—metabolic syndrome X	0.000433	0.000736	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RBP4—metabolic syndrome X	0.000433	0.000736	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—AKT1—metabolic syndrome X	0.00043	0.00073	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GHRL—metabolic syndrome X	0.000428	0.000728	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AGT—metabolic syndrome X	0.000427	0.000725	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—AKT1—metabolic syndrome X	0.000426	0.000723	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—AKT1—metabolic syndrome X	0.000424	0.00072	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—IRS1—metabolic syndrome X	0.000419	0.000712	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—IL6—metabolic syndrome X	0.000416	0.000707	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOC3—metabolic syndrome X	0.000415	0.000705	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000414	0.000704	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AGT—metabolic syndrome X	0.00041	0.000697	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—AKT1—metabolic syndrome X	0.000408	0.000694	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL5—metabolic syndrome X	0.000408	0.000693	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	0.000408	0.000693	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000406	0.00069	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000406	0.00069	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CNR1—metabolic syndrome X	0.000405	0.000689	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RBP4—metabolic syndrome X	0.000404	0.000686	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000404	0.000686	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—LEP—metabolic syndrome X	0.000402	0.000683	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOE—metabolic syndrome X	0.000402	0.000683	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—AKT1—metabolic syndrome X	0.000401	0.000682	CbGpPWpGaD
Amlexanox—FGF1—Disease—SLC2A4—metabolic syndrome X	0.0004	0.000679	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOA1—metabolic syndrome X	0.000397	0.000675	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HTR2C—metabolic syndrome X	0.000393	0.000668	CbGpPWpGaD
Amlexanox—FGF1—Immune System—VCAM1—metabolic syndrome X	0.000393	0.000668	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AGT—metabolic syndrome X	0.000387	0.000658	CbGpPWpGaD
Amlexanox—FGF1—Disease—GOT1—metabolic syndrome X	0.000387	0.000658	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—metabolic syndrome X	0.000384	0.000652	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOC3—metabolic syndrome X	0.000384	0.000652	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CYBA—metabolic syndrome X	0.000381	0.000647	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AGT—metabolic syndrome X	0.000376	0.000638	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000374	0.000636	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GHRL—metabolic syndrome X	0.000373	0.000633	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AGT—metabolic syndrome X	0.000369	0.000627	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—CCL2—metabolic syndrome X	0.000366	0.000623	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CYBA—metabolic syndrome X	0.000362	0.000616	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IRS1—metabolic syndrome X	0.000359	0.000609	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOC3—metabolic syndrome X	0.000358	0.000608	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GHRL—metabolic syndrome X	0.000355	0.000603	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CNR1—metabolic syndrome X	0.000353	0.0006	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL18—metabolic syndrome X	0.000347	0.00059	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HTR2C—metabolic syndrome X	0.000346	0.000588	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—INS—metabolic syndrome X	0.000343	0.000584	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AGT—metabolic syndrome X	0.000341	0.00058	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCL2—metabolic syndrome X	0.000338	0.000574	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CNR1—metabolic syndrome X	0.000336	0.000571	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CYBA—metabolic syndrome X	0.000335	0.00057	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1—metabolic syndrome X	0.000332	0.000564	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF2—metabolic syndrome X	0.000331	0.000563	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOB—metabolic syndrome X	0.000329	0.000558	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GHRL—metabolic syndrome X	0.000328	0.000558	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HTR2C—metabolic syndrome X	0.000323	0.000549	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD36—metabolic syndrome X	0.000323	0.000549	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOB—metabolic syndrome X	0.000322	0.000547	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—IL6—metabolic syndrome X	0.00032	0.000544	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—IL6—metabolic syndrome X	0.000319	0.000543	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—CCL2—metabolic syndrome X	0.000319	0.000542	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000315	0.000536	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL5—metabolic syndrome X	0.000314	0.000534	CbGpPWpGaD
Amlexanox—FGF1—Disease—LPL—metabolic syndrome X	0.000314	0.000533	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000313	0.000532	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CYBA—metabolic syndrome X	0.000313	0.000531	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CNR1—metabolic syndrome X	0.000311	0.000528	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LPL—metabolic syndrome X	0.000307	0.000522	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GHRL—metabolic syndrome X	0.000306	0.00052	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000304	0.000516	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—metabolic syndrome X	0.000301	0.000512	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—AKT1—metabolic syndrome X	0.000295	0.000502	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—AKT1—metabolic syndrome X	0.000295	0.000501	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CRP—metabolic syndrome X	0.000291	0.000495	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CNR1—metabolic syndrome X	0.00029	0.000493	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF2—metabolic syndrome X	0.000289	0.00049	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000281	0.000477	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOB—metabolic syndrome X	0.00028	0.000476	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF2—metabolic syndrome X	0.000275	0.000467	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL5—metabolic syndrome X	0.000274	0.000465	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000273	0.000463	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LPL—metabolic syndrome X	0.000267	0.000455	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOB—metabolic syndrome X	0.000267	0.000453	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—metabolic syndrome X	0.000263	0.000447	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AGT—metabolic syndrome X	0.000263	0.000447	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL5—metabolic syndrome X	0.00026	0.000442	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOA1—metabolic syndrome X	0.00026	0.000442	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000259	0.000441	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000258	0.000439	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—metabolic syndrome X	0.000258	0.000438	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—LEP—metabolic syndrome X	0.000258	0.000438	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOA1—metabolic syndrome X	0.000255	0.000433	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LPL—metabolic syndrome X	0.000255	0.000433	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF2—metabolic syndrome X	0.000254	0.000432	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IRS1—metabolic syndrome X	0.000254	0.000432	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—IL6—metabolic syndrome X	0.000254	0.000432	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOB—metabolic syndrome X	0.000247	0.000419	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL5—metabolic syndrome X	0.000241	0.000409	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00024	0.000408	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF2—metabolic syndrome X	0.000237	0.000403	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LPL—metabolic syndrome X	0.000236	0.0004	CbGpPWpGaD
Amlexanox—FGF1—Disease—IRS1—metabolic syndrome X	0.000235	0.000399	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AKT1—metabolic syndrome X	0.000234	0.000398	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL6—metabolic syndrome X	0.000232	0.000394	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOB—metabolic syndrome X	0.00023	0.000391	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IRS1—metabolic syndrome X	0.00023	0.00039	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AGT—metabolic syndrome X	0.000229	0.000389	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL5—metabolic syndrome X	0.000225	0.000382	CbGpPWpGaD
Amlexanox—FGF1—Disease—INS—metabolic syndrome X	0.000225	0.000382	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—metabolic syndrome X	0.000224	0.000381	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—LEP—metabolic syndrome X	0.000224	0.000381	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000224	0.00038	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOA1—metabolic syndrome X	0.000222	0.000377	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—INS—metabolic syndrome X	0.00022	0.000374	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LPL—metabolic syndrome X	0.00022	0.000373	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AGT—metabolic syndrome X	0.000218	0.00037	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCL2—metabolic syndrome X	0.000216	0.000368	CbGpPWpGaD
Amlexanox—IL3—Immune System—AKT1—metabolic syndrome X	0.000214	0.000364	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—LEP—metabolic syndrome X	0.000213	0.000363	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—metabolic syndrome X	0.000213	0.000363	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—metabolic syndrome X	0.000213	0.000362	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOA1—metabolic syndrome X	0.000211	0.000359	CbGpPWpGaD
Amlexanox—FGF1—Disease—SERPINE1—metabolic syndrome X	0.000206	0.000351	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000202	0.000343	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AGT—metabolic syndrome X	0.000202	0.000342	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IRS1—metabolic syndrome X	0.0002	0.00034	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TGFB1—metabolic syndrome X	0.000199	0.000338	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LEP—metabolic syndrome X	0.000197	0.000336	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—metabolic syndrome X	0.000197	0.000336	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—metabolic syndrome X	0.000197	0.000335	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOA1—metabolic syndrome X	0.000195	0.000332	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—metabolic syndrome X	0.000193	0.000328	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—INS—metabolic syndrome X	0.000192	0.000325	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IRS1—metabolic syndrome X	0.00019	0.000324	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCL2—metabolic syndrome X	0.000188	0.00032	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AGT—metabolic syndrome X	0.000188	0.000319	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL6—metabolic syndrome X	0.000186	0.000316	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—metabolic syndrome X	0.000185	0.000315	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LEP—metabolic syndrome X	0.000184	0.000313	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—metabolic syndrome X	0.000184	0.000313	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—IL6—metabolic syndrome X	0.000183	0.00031	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—INS—metabolic syndrome X	0.000182	0.00031	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOA1—metabolic syndrome X	0.000182	0.000309	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—metabolic syndrome X	0.00018	0.000306	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCL2—metabolic syndrome X	0.000179	0.000305	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—metabolic syndrome X	0.000176	0.0003	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IRS1—metabolic syndrome X	0.000176	0.000299	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000176	0.000299	CbGpPWpGaD
Amlexanox—S100A12—Immune System—AKT1—metabolic syndrome X	0.000172	0.000292	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—INS—metabolic syndrome X	0.000169	0.000287	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—AKT1—metabolic syndrome X	0.000168	0.000286	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—metabolic syndrome X	0.000168	0.000285	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000167	0.000285	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCL2—metabolic syndrome X	0.000166	0.000282	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000165	0.000281	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IRS1—metabolic syndrome X	0.000164	0.000279	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—metabolic syndrome X	0.000163	0.000277	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL6—metabolic syndrome X	0.000163	0.000277	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—AKT1—metabolic syndrome X	0.000162	0.000275	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—metabolic syndrome X	0.00016	0.000272	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—INS—metabolic syndrome X	0.000157	0.000267	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000155	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCL2—metabolic syndrome X	0.000155	0.000263	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—metabolic syndrome X	0.000152	0.000259	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AKT1—metabolic syndrome X	0.00015	0.000255	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL6—metabolic syndrome X	0.00015	0.000255	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—metabolic syndrome X	0.000148	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000144	0.000246	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000144	0.000245	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL6—metabolic syndrome X	0.000142	0.000241	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AKT1—metabolic syndrome X	0.000138	0.000235	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—metabolic syndrome X	0.000138	0.000234	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000137	0.000233	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL6—metabolic syndrome X	0.000135	0.000229	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AKT1—metabolic syndrome X	0.000131	0.000222	CbGpPWpGaD
Amlexanox—FGF1—Disease—TGFB1—metabolic syndrome X	0.00013	0.000221	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TGFB1—metabolic syndrome X	0.000128	0.000217	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000127	0.000215	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL6—metabolic syndrome X	0.000125	0.000212	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AKT1—metabolic syndrome X	0.000124	0.000211	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AKT1—metabolic syndrome X	0.000115	0.000196	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TGFB1—metabolic syndrome X	0.000111	0.000189	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL6—metabolic syndrome X	0.000106	0.000181	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TGFB1—metabolic syndrome X	0.000106	0.00018	CbGpPWpGaD
Amlexanox—FGF1—Disease—IL6—metabolic syndrome X	9.82e-05	0.000167	CbGpPWpGaD
Amlexanox—FGF1—Immune System—AKT1—metabolic syndrome X	9.81e-05	0.000167	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TGFB1—metabolic syndrome X	9.78e-05	0.000166	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL6—metabolic syndrome X	9.61e-05	0.000163	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TGFB1—metabolic syndrome X	9.12e-05	0.000155	CbGpPWpGaD
Amlexanox—FGF1—Disease—AKT1—metabolic syndrome X	9.05e-05	0.000154	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AKT1—metabolic syndrome X	8.87e-05	0.000151	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL6—metabolic syndrome X	8.37e-05	0.000142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL6—metabolic syndrome X	7.97e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AKT1—metabolic syndrome X	7.72e-05	0.000131	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL6—metabolic syndrome X	7.37e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AKT1—metabolic syndrome X	7.35e-05	0.000125	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL6—metabolic syndrome X	6.87e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AKT1—metabolic syndrome X	6.8e-05	0.000116	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AKT1—metabolic syndrome X	6.34e-05	0.000108	CbGpPWpGaD
